Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

German SLD-Registry Characterization of Patients With Steatotic Liver Disease (SLD) in Germany - Phase 1 (Observation of the Natural Course)

NCT04721665 is registered in ClinicalTrials.gov with Leberstiftungs-GmbH Deutschland as lead sponsor.

NCT NCT04721665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04721665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
German SLD-Registry Characterization of Patients With Steatotic Liver Disease (SLD) in Germany - Phase 1 (Observation of the Natural Course)
Lead sponsor
Leberstiftungs-GmbH Deutschland
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
April 16, 2026
Enrollment
1,681 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

steatotic liver disease